ReShape Lifesciences Past Earnings Performance
Past criteria checks 0/6
ReShape Lifesciences has been growing earnings at an average annual rate of 9.2%, while the Medical Equipment industry saw earnings growing at 8.7% annually. Revenues have been declining at an average rate of 0.8% per year.
Key information
9.2%
Earnings growth rate
78.4%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | -0.8% |
Return on equity | -240.8% |
Net Margin | -131.0% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
It's A Story Of Risk Vs Reward With ReShape Lifesciences Inc. (NASDAQ:RSLS)
Apr 18ReShape wins FDA clearance for device used in weight loss surgery
Aug 10Analysts Have Lowered Expectations For ReShape Lifesciences Inc. (NASDAQ:RSLS) After Its Latest Results
Mar 31Health Check: How Prudently Does ReShape Lifesciences (NASDAQ:RSLS) Use Debt?
Dec 09Does ReShape Lifesciences (NASDAQ:RSLS) Have A Healthy Balance Sheet?
Aug 24Revenue & Expenses Breakdown
How ReShape Lifesciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 8 | -11 | 14 | 2 |
31 Dec 23 | 9 | -11 | 18 | 2 |
30 Sep 23 | 10 | -26 | 21 | 2 |
30 Jun 23 | 10 | -35 | 26 | 2 |
31 Mar 23 | 11 | -41 | 29 | 2 |
31 Dec 22 | 11 | -46 | 31 | 3 |
30 Sep 22 | 11 | -66 | 33 | 2 |
30 Jun 22 | 12 | -72 | 40 | 3 |
31 Mar 22 | 13 | -66 | 36 | 3 |
31 Dec 21 | 14 | -63 | 31 | 2 |
30 Sep 21 | 14 | -35 | 27 | 3 |
30 Jun 21 | 14 | -22 | 15 | 2 |
31 Mar 21 | 12 | -22 | 15 | 3 |
31 Dec 20 | 11 | -22 | 15 | 3 |
30 Sep 20 | 12 | -38 | 16 | 3 |
30 Jun 20 | 12 | -62 | 18 | 3 |
31 Mar 20 | 15 | -74 | 21 | 3 |
31 Dec 19 | 15 | -74 | 22 | 3 |
30 Sep 19 | 11 | -52 | 22 | 3 |
30 Jun 19 | 8 | -28 | 21 | 3 |
31 Mar 19 | 4 | -35 | 18 | 4 |
31 Dec 18 | 1 | -38 | 19 | 6 |
30 Sep 18 | 0 | -42 | 22 | 7 |
30 Jun 18 | 1 | -47 | 22 | 8 |
31 Mar 18 | 1 | -30 | 23 | 7 |
31 Dec 17 | 1 | -30 | 23 | 5 |
30 Sep 17 | 1 | -29 | 19 | 5 |
30 Jun 17 | 1 | -25 | 18 | 5 |
31 Mar 17 | 1 | -23 | 18 | 5 |
31 Dec 16 | 1 | -23 | 18 | 5 |
30 Sep 16 | 1 | -26 | 21 | 6 |
30 Jun 16 | 1 | -23 | 22 | 6 |
31 Mar 16 | 0 | -26 | 21 | 7 |
31 Dec 15 | 0 | -25 | 20 | 8 |
30 Sep 15 | 0 | -25 | 17 | 9 |
30 Jun 15 | 0 | -26 | 16 | 10 |
31 Mar 15 | 0 | -27 | 15 | 11 |
31 Dec 14 | 0 | -26 | 15 | 11 |
30 Sep 14 | 0 | -27 | 15 | 11 |
30 Jun 14 | 0 | -27 | 15 | 11 |
31 Mar 14 | 0 | -26 | 14 | 11 |
31 Dec 13 | 0 | -26 | 14 | 11 |
30 Sep 13 | 0 | -26 | 14 | 11 |
Quality Earnings: RSLS is currently unprofitable.
Growing Profit Margin: RSLS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RSLS is unprofitable, but has reduced losses over the past 5 years at a rate of 9.2% per year.
Accelerating Growth: Unable to compare RSLS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RSLS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.3%).
Return on Equity
High ROE: RSLS has a negative Return on Equity (-240.8%), as it is currently unprofitable.